NCT01723956

Brief Summary

To compare the efficacy of cryotherapy and large loop excision of the transformation zone (LLETZ) procedures for the treatment of high-grade cervical intra-epithelial neoplasia (CIN2/3) among HIV-seropositive women by follow-up VIA, cytology and Human Papillomavirus. Hypothesis: LEEP will be more effective than cryotherapy in removing CIN 2/3 lesions in HIV positive women in South Africa

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

November 6, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 8, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

September 22, 2014

Status Verified

August 1, 2014

Enrollment Period

4.4 years

First QC Date

November 6, 2012

Last Update Submit

September 19, 2014

Conditions

Keywords

Cervical DysplasiaCin 2Cin 3HIV positive womenSouth Africa

Outcome Measures

Primary Outcomes (1)

  • Compare efficacy of cryotherapy and LEEP

    To compare the efficacy of cryotherapy and large loop excision of the transformation zone (LLETZ) procedures for the treatment of high-grade cervical intra-epithelial neoplasia (CIN2/3) among HIV-seropositive women by follow-up VIA, cytology and HPV.

    1 year

Secondary Outcomes (4)

  • The ability to use Human Papillomavirus as the measure of treatment success

    1 year

  • To compare the safety of cryotherapy versus LLETZ in HIV seropositive women

    1 month, 6 months and 12 months

  • Describe factors associated with successful treatment of CIN 2/3

    1 year

  • To determine the cervical disease recurrence rates with cryotherapy and LLETZ.

    6 months and 12 months

Study Arms (2)

Arm B

ACTIVE COMPARATOR

LEEP treatment of CIN 2/3 cervical lesion in HIV positive women (standard of Care)

Procedure: LEEP

Arm A

EXPERIMENTAL

Cryotherapy treatment of CIN 2/3 cervical lesions

Procedure: Cryotherapy

Interventions

CryotherapyPROCEDURE

This is involves freezing the lesions with a cryo gun using Nitrous Oxide for 3 minutes-- wait 5 minutes and then refreezing for 3 more minutes. This procedure uses the Wallach cryogun

Also known as: This is a study using Freezing with a cryogun
Arm A
LEEPPROCEDURE

The cervix is anaesthetized with lidocaine and then a electric loop is applied to the cervical lesion which is cut with one pass. The LEEP machine used is the automatic Finesse Machine.

Also known as: Loop Electric Excision Procedure
Arm B

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women 18-65 years of age
  • Not menstruating (if menstruating, the patient can be screened at another date)
  • Able to sign consent
  • Able to follow the study protocol
  • HIV positive (by two different criteria; either 2 different rapid HPV tests of different manufacturers, a HIV viral load ≥5,000,ELISA, Western blot documented in VICAR 1)
  • Participant with histology-proven CIN 2 or 3 disease

You may not qualify if:

  • Pregnant
  • Clinically active sexually transmitted disease determined by clinical history and/or physical exam (may participate after adequate treatment by syndromic treatment management)
  • Known and previous treatment for high grade squamouse intraepithelial lesion by any method (cryotherapy, LLETZ or cone biopsy)
  • Previous hysterectomy with removal of the cervix
  • Significant medical illness/mental illness that the investigator feels would prevent the participant from complying with the protocol or place the participant at medical risk
  • Cervical dysplastic lesions that are not appropriate for cryotherapy, defined as the following:
  • Lesion is greater than ≥75% cervix
  • Lesion entering into the cervical canal and the complete lesion cannot be visualized
  • Presence of abnormal vasculature
  • Lesion bigger that the cryotherapy probe

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helen Joseph Hospital

Johannesburg, Gauteng, 2092, South Africa

Location

Related Publications (1)

  • Smith JS, Sanusi B, Swarts A, Faesen M, Levin S, Goeieman B, Ramotshela S, Rakhombe N, Williamson AL, Michelow P, Omar T, Hudgens MG, Firnhaber C. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017 Aug;217(2):183.e1-183.e11. doi: 10.1016/j.ajog.2017.03.022. Epub 2017 Mar 31.

MeSH Terms

Conditions

Uterine Cervical Dysplasia

Interventions

Cryotherapy

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Cynthia S Firnhaber, MD

    University of Witwatersrand, South Africa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

November 6, 2012

First Posted

November 8, 2012

Study Start

March 1, 2010

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

September 22, 2014

Record last verified: 2014-08

Locations